Skip to main content
NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
CO

Codexis, Inc. (CDXS)

NASDAQ • Healthcare

$1.43
+$0 (+0.0%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$1.43
Previous Close$1.43
Day Range$1.42 - $1.45
Avg. Volume (3M)1M
Market Cap$153.2M
52 Week Range
$0.96$2.98
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$14.9M100%
Gross Profitminus cost of goods$11.4M76%

In plain terms: out of every $100 in revenue, Codexis, Inc. currently loses $80.

Fundamentals & Financials

Revenue (TTM)
$77.6M
Net Income (TTM)
-$30.7M
EPS (TTM)
-$0.34
ROA (TTM)
-25.59%
Current Ratio
3.06

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1000.0%Q1 2026$0.11
+9.1%Q2 2026-$0.1
+8.2%Q3 2026-$0.13
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Codexis, Inc.

Codexis, Inc. develops enzyme engineering and biocatalysis tools for the biotechnology end of healthcare and trades on the NASDAQ as CDXS. In FY2025, the company recorded $70.4 million in revenue from products and services used by pharmaceutical manufacturers, including advanced biocatalyst products, screening tools, and protein engineering work.

Name
Codexis, Inc.
CEO
Alison Moore
Website
www.codexis.com
Industry
Healthcare
Year Founded
2002
Employees
146

Today's Snapshot

AI-generated

CDXS is slightly lower at 1.43 so far today, in line with a flat sector. Codexis highlighted progress in enzymatic RNA manufacturing at an investor conference.

Trading Volume

Below 10d avg (783.5K)

216.9K

vs S&P 500 Today

Moderate Outperformance

+0.27%

Updated: September 10, 2026 at 16:41 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
CDXS presents a strong sell signal driven by clear weakness across momentum, price structure, and volume. Momentum and MACD are negative and CCI is deeply oversold, while the price sits beneath short-, medium- and long-term moving averages and on-balance volume is trending lower. ADX indicates a modest directional reading but volatility is elevated with ATR around 7.0%, amplifying downside moves, and the pivot sits near the current level offering little support. Technical takeaway: strong sell — pervasive momentum and moving-average breakdowns, reinforced by weak volume and higher volatility.
All signals
  • EMA (5 indicators)$1.49 - $1.92
    Sell
  • RSI (14)37.80
    Neutral
  • Stochastic %K (14, 3, 3)5.06
    Buy
  • MACD Level (12, 26)-0.08
    Sell

Peers & Related Assets

OABIOmniAb, Inc.
$4.01-5.4%
GNFTGenfit S.A.
CCCCC4 Therapeutics, Inc.
IVVDInvivyd, Inc.
TARAProtara Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.